Archive | Drugs RSS feed for this section

addiction brain image

Wasted: New hope for addiction treatment

Do you know someone with an addiction problem? Last October, I attended a lecture at the University of Toronto given by Mark Lewis, Ph.D., a neuroscientist and professor of developmental psychology. A former addict himself and author of The Biology of Desire: Why Addiction is not a Disease, Lewis said that addiction is not a […]

Read full story · Comments { 0 }

Addyi FDA Approval: Premature Approbation?

On August 18, 2015, the FDA approved Addyi (flibanserin), a drug to treat “acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.” The FDA defines HSDD as “low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the […]

Read full story · Comments { 0 }

Tags: , , , , , , , , , ,

JetFuel Superburn supplement

What’s really in supplements?

Would you trust prescription medication that only contained the active ingredient 21-48% of the time? Would you trust medication that contained undisclosed ingredients 40% of the time? Not a chance? Then why do so many people trust unproven, unregulated supplements? On February 3, 2015, the New York State Attorney General Eric T. Schneiderman issued a series of […]

Read full story · Comments { 0 }

Tags: , , , , , , , , , , , , , ,

new drug dificid for c difficile

Biotech Firm Wins FDA Approval for C. Difficile Antibiotic

The number of newly approved antibiotics has declined significantly since the 1980s as large pharmaceutical companies have mostly withdrawn from research and development in this critical market segment. Fortunately, the biotech industry is now stepping up to the plate to develop much-needed antibiotics to fight a rising number of drug-resistant superbugs, such as Clostridium difficile (or C. […]

Read full story · Comments { 0 }

Tags: , , , , , , , ,

Task Force Recommends Against HRT for Postmenopausal Women

Considering hormone replacement therapy (HRT) to prevent chronic medical conditions? News flash! HRT is no longer recommended for post-menopausal women, because the health risks outweigh the benefits. The U.S. Preventive Services Task Force has just issued an updated statement, which you can review here. The recommendation is based on research published since 2005 and it […]

Read full story · Comments { 0 }

Tags: , , , , , , , , , , , ,

atrial fibrillation

Designer Drugs for Atrial Fibrillation Patients

Three new game-changing anticoagulants have been developed for the prevention of strokes in people with atrial fibrillation. The new designer drugs dabigatran, rivaroxaban and apixaban offer significant benefits compared to decades-old warfarin, but there are some downsides to consider. More than 2.7 million Americans have atrial fibrillation today and an estimated 12 million may have […]

Read full story · Comments { 2 }

Tags: , , , , , , , , , , , , , , , ,

Is My Cancer Different?

Cancer patients benefit from new molecular testing advances that inform individualized, targeted treatment plans. We all know someone whose life was severely impacted by or ended by cancer. In fact, the words we may fear hearing the most are, “You’ve got cancer,” a diagnosis that can be scary, confusing, stressful and overwhelming. More than 12.7 […]

Read full story · Comments { 1 }

Tags: , , , , , , , , , ,

FDA Approves INCIVEK to Treat Hepatitis C

This story was published on GE Healthy Outlook last spring after the FDA approved INCIVEK. I spoke with Jordan Feld, MD MPH, hepatologist at the Toronto Western Hospital Liver Clinic and clinician scientist at the McLaughlin-Rotman Centre for Global Health at the University of Toronto, to find out what this new drug could mean for patients […]

Read full story · Comments { 0 }

Tags: , , , , , , , , , , ,

First New Lupus Drug in 50 Years: Benlysta Gains FDA Approval

For the first time in over 50 years, the U.S. Food and Drug Administration (FDA) has approved a new drug for lupus, a breakthrough drug called Benlysta (belimumab). Anca D. Askanase, MD, MPH was Principal Investigator at the New York University site for Benlysta research and also serves as a Member of the Lupus Foundation of America’s […]

Read full story · Comments { 0 }

Tags: , , , , , , , ,